[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Huge Unusual Put Options Volume in Merck - Is MRK Stock Overvalued?

A Barchart report shows that despite recent strong Q2 results and a 10% spike in Merck stock today, an unusually large volume of put options has traded at a much lower strike price. Is MRK stock overvalued?...

MRK : 152.42 (+12.76%)
Merck (MRK) Stock Trades Up, Here Is Why

Merck (MRK) Stock Trades Up, Here Is Why

MRK : 152.42 (+12.76%)
This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results

Moderna stock rips higher on a major cancer breakthrough. The announcement led William Blair to upgrade MRNA shares to "Outperform."

MRK : 152.42 (+12.76%)
MRNA : 154.83 (+145.92%)
Stocks Supported by Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) is up by +0.58% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.07%. E-mini S&P futures (ESU26...

MSTR : 103.75 (+12.14%)
HL : 20.05 (+11.70%)
CDE : 20.71 (+11.89%)
GLXY : 21.62 (+5.82%)
TRI : 105.79 (+5.54%)
COIN : 160.02 (+9.43%)
STX : 835.44 (-7.55%)
WDC : 461.89 (-6.91%)
AMD : 466.02 (-3.79%)
SCCO : 194.20 (+3.41%)
^BTCUSD : 68,335.14 (+5.89%)
SPY : 769.91 (+0.32%)
Stocks Mixed on Lower Bond Yields and Chip Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) is up by +0.33% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.33%. E-mini S&P futures...

AMAT : 492.63 (-4.22%)
B : 44.60 (+5.96%)
AVGO : 364.76 (-4.01%)
HL : 20.05 (+11.70%)
INTU : 363.12 (+3.63%)
SNDK : 1,560.73 (-4.00%)
CDE : 20.71 (+11.89%)
MRK : 152.42 (+12.76%)
TRI : 105.79 (+5.54%)
$IUXX : 29,444.49 (-0.16%)
ZNU26 : 108-230 (+0.14%)
ESU26 : 7,736.75 (+0.29%)
Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

First and only combination regimen to demonstrate statistically significant and clinically meaningful improvements in RFS and DMFS compared to KEYTRUDA alone for these patients in the adjuvant melanoma...

MRK : 152.42 (+12.76%)
MRNA : 154.83 (+145.92%)
5 Insightful Analyst Questions From Merck’s Q2 Earnings Call

5 Insightful Analyst Questions From Merck’s Q2 Earnings Call

MRK : 152.42 (+12.76%)
Merck & Co’s Stock: Analyst Estimates & Ratings

Merck has outperformed the broader market over the past year, and analysts remain optimistic about the stock.

XLV : 175.82 (+3.59%)
$SPX : 7,715.25 (+0.31%)
MRK : 152.42 (+12.76%)
U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season

EMA also accepts application for the same population for ENFLONSIA based on results from the Phase 3 SMART trial If approved, children under two years of age at increased...

MRK : 152.42 (+12.76%)
MRK Q2 Deep Dive: Oncology and New Launches Drive Growth Amid Margin Compression

MRK Q2 Deep Dive: Oncology and New Launches Drive Growth Amid Margin Compression

MRK : 152.42 (+12.76%)

Barchart Exclusives

Here Is How to Play Tesla Stock After Its Robotaxi Breakthrough
Tesla progresses with its robotaxi plans with a soft public rollout being the next phase. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.